Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

Transdifferentiation of fibroblasts to urothelial progenitors for definitive urothelial replacement therapy in non-muscle invasive bladder cancer

Funder: Bladder Cancer Advocacy Network

Funding period
USD 300 K
Funding amount
Abstract
Intermediate or high-risk non-muscle invasive bladder cancer that is refractory to Bacillus Calmette-Guérin has limited treatment options. Intravesical chemotherapy has limited efficacy, and radical cystectomy with urinary diversion, though effective in terms of recurrence-free survival, has a high rate of complications. As an alternative to radical cystectomy with urinary diversion in patients with recurrent non-muscle invasive bladder cancer, we propose to replace the bladder urothelium. The basis of this proposal centers upon our work in understanding how in the mouse, a lesion similar to human carcinoma in situ (CIS) develops from exposure to a carcinogenic agent and extensively proliferates to involve most, if not all, of the urothelium, necessitating complete urothelial replacement to avoid cancer recurrence and progression. In order to replace the urothelium, we must develop methods to generate bladder urothelial progenitor cells, and we propose to do this through transdifferentiation of fibroblasts. We will also develop methods to exfoliate the urothelium and transplant these cells, as well as measure the extent of the premalignant lesion. We hypothesize that replacement of the urothelium with urothelial progenitor cells from transdifferentiation will definitively prevent progression and recurrence of non-muscle invasive bladder cancer.
Similar projects All >
Sorted by: Start Date
Project list item
Defining NRF2 induced tumor invasion in bladder cancer

Bladder Cancer Advocacy Network to Yuki Kita, William Youngkwan Kim, Bernard Weissman

USD 50,000
2020 - 2021
Project list item
Targeting regulatory B cells (Bregs) to improve anti-bladder cancer immunity

Bladder Cancer Advocacy Network to Burles Avner Johnson, David McConkey

USD 50,000
2020 - 2021
Project list item
Implication of neutrophil extracellular traps in the efficacy of bladder-sparing therapy in muscle invasive bladder cancer

Canadian Institutes of Health Research to Wassim Kassouf, Jonathan David Spicer, Ciriaco A. Piccirillo

USD 138,878
2020 - 2025
Project list item
Dissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer

National Cancer Institute to NINA BHARDWAJ, JUN ZHU, MATTHEW GALSKY

USD 703,400
2020 - 2025
Project list item
CD40 agonism for the treatment of bladder cancer

National Cancer Institute to CHRISTOPHER STUART GARRIS

USD 64,554
2020 - 2023

System

Categories
  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Stem Cell Research

  • RCDC

    Cancer

  • RCDC

    Stem Cell Research - Nonembryonic - Non-Human

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Clinical Medicine and Science